Federal Register MedWatch Pharma News Warning Letters
Halfan (halofantrine hydrochloride) Tablets, 250 mg, GlaxoSmithKline NDA 20-250/S-007, S-008
For the most up-to-date approval information, please locate this API using the drug index.